Isoflavone G-2535

genistein

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Isoflavone G-2535, covering 2016-03-24 to 2016-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer [Phase 2]